T0	Participants 0 39	Outcome assessment for clinical trials:
T1	Participants 49 61	adjudicators
T2	Participants 370 420	adjudication committee in a large randomized trial
T3	Participants 453 486	potentially operable lung cancer.
T4	Participants 487 522	Up to five independent adjudicators
T5	Participants 638 646	Patients
T6	Participants 1367 1374	patient